IHH Healthcare (“IHH” or the “Group”), a leading multinational healthcare provider, today welcomed shareholders to its 16th Annual General Meeting (“AGM”) for the financial year ended 31 December 2025.
Held in hybrid format at the KLGCC Convention Centre in Kuala Lumpur and via live streaming, shareholders and proxies approved all 10 ordinary resolutions tabled, including the re-election of directors, the re-appointment of KPMG as Auditors, and the renewal of the Group’s share buy-back authority.
FY2025: Strong core performance underpins higher dividend; on track for double-digit return on equity by 2028
IHH delivered strong underlying growth in FY2025. Core revenue rose 18% year-on-year to RM26.2 billion, EBITDA increased 14% to RM5.8 billion, and PATMI (excluding exceptional items) grew 3% to RM2.3 billion. Performance was led by especially strong execution in Malaysia and India. Reflecting this, the Board declared a final cash dividend of 5.5 sen per share, bringing total ordinary dividends for FY2025 to 10.5 sen per share, up from 10.0 sen for FY2024. The total payout represents more than 40% of PATMI (excluding exceptional items), well above the Group’s stated dividend policy of at least 30%.
Return on equity (“ROE”), excluding exceptional items and MFRS129 effects, was around 9% for FY2025, keeping IHH firmly on track towards its target of double-digit ROE by 2028.
Transformation gathers pace
IHH's multi-year transformation - designed to future-proof the business and catalyse sustainable growth, made accelerated progress in FY2025.
Anchoring this are several enterprise-wide initiatives. The first is the implementation of a cloud-based treasury management platform with embedded AI tools that automate key tasks such as cash management and forecasting, liquidity planning and hedge accounting. Phase 1 has started in Singapore, Malaysia and Hong Kong, with phase 2 progressively extending to other markets.
Another initiative consolidates IHH's enterprise systems across finance, human resources and procurement into a single, integrated and scalable platform. The platform's three core modules - Enterprise Resource Planning, Human Capital Management, and Supply Chain Management – will drive process effectiveness, deepen workforce insights, and strengthen visibility into inventories and supply chain resilience. Rollout will begin in Malaysia, Singapore and Hong Kong progressively from Q4 2026.
Steady progress on sustainability; 2030 roadmap launched
IHH did well on its 2025 Sustainability Goals, achieving 14 of 16 targets across the four pillars of Patients, People, Public and Planet. Building on this, the Group launched its 2030 sustainability goals in April 2026, including a 42% reduction in Scope 1 and 2 emissions (from a 2025 baseline), supplier engagement to encourage emissions reporting, and new water and waste targets. Details are available in IHH's Sustainability Report 2025.
Positioned for sustainable, long-term growth
Near-term macro conditions continues to be volatile, but the Group expects demand for quality healthcare to remain strong. IHH will keep growing daycare volumes in Malaysia, ramp up contributions from Mount Elizabeth Orchard in Singapore, extract greater clinical and operational synergies between Fortis Healthcare and Gleneagles in India, and sustain Acibadem’s market leadership in Türkiye, among other priorities.
Through our execution of country-specific initiatives, disciplined capital allocation, and technology-enabled productivity, the Group is well-positioned to achieve double-digit ROE by 2028, and deliver sustainable value for patients, partners and shareholders, in line with its aspiration to Care. For Good.
